Figure 7. Carbon nanotubes have the ability to penetrate cells and release caspase-3.
Cell viability on day 1 (A) and day 3 (B) of MG-63 cells under exposure to differing dosages of CNTs, CNT-PLGA, CNT-PLGA-BSA, caspase-3, Pro-Ject and CNT-PLGA-CP3 treatment. * means significant difference of cell viability under CNT-PLGA-CP3 cojugate exposure and other groups of same dosage.